The Health Law Firm

MAY 28, 2015

By George F. Indest III, J.D., M.P.A., LL.M, Board Certified by the Florida Bar in Health Law We are often asked by medical groups, health care clinics, and other care providers whether they are legally allowed to treat those working for them as independent contractors. In attempting to determine whether an individual may be treated as an independent contractor or an employee, it is useful to apply the Internal Revenue Service (IRS) "20 Factor Test.

Medicare 40

Medicare Medicare 40

The Health Law Firm

MAY 15, 2015

After much political wrangling and lobbying, in 2009, Florida enacted the Electronic-Florida Online Reporting of Controlled Substances Evaluation (E-FORCSE), currently codified in Section 893.055, Florida Statutes. More often, it is referred to simply as the prescription drug monitoring program (PDMP) by Florida physicians. Since the beginning, the PDMP has been plagued with issues ranging from funding, patient privacy concerns and the legal uses of the database.

40

40

The Health Law Firm

MAY 12, 2015

By George F. Indest III, J.D., M.P.A., LL.M., Board Certified by The Florida Bar in Health Law Have you ever been arrested for a criminal offense? Have you ever had discipline on your license as a health professional? Have you ever been assessed a repayment or fine by the Medicare or Medicaid Programs? If so, then you may have also been terminated from or excluded from the federal Medicare Program or your state Medicaid Program.

Medicaid 40

Medicaid Medicaid Medicare Medicare 40

The Health Law Firm

MAY 1, 2015

One of the toughest things families of people with substance abuse problems encounter is convincing loved ones to get the help they need. In the state of Florida, there is a law called the Marchman Act which may allow some relief. What is the Marchman Act? The Marchman Act is very similar to the Baker Act, in that it allows for the involuntary confinement of a person in order to receive treatment for a substance abuse problem.

40

40

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!